# ImmunityBio, Inc.: Form 8-K, filed Sep 2, 2022

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2022-09-02
- Accepted by EDGAR: Sep 2, 2022, 16:15 ET
- Period: 2022-08-31
- Accession: 0001326110-22-000064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000132611022000064/ibrx-20220831.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000132611022000064/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000132611022000064/ibrx-20220831.htm

Filed Sep 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001326110-22-000064. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
